Correlation Between Ikena Oncology and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Nuvectis Pharma, you can compare the effects of market volatilities on Ikena Oncology and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Nuvectis Pharma.
Diversification Opportunities for Ikena Oncology and Nuvectis Pharma
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Ikena and Nuvectis is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Ikena Oncology and Nuvectis Pharma
Given the investment horizon of 90 days Ikena Oncology is expected to generate 1.06 times more return on investment than Nuvectis Pharma. However, Ikena Oncology is 1.06 times more volatile than Nuvectis Pharma. It trades about 0.01 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.01 per unit of risk. If you would invest 330.00 in Ikena Oncology on November 2, 2024 and sell it today you would lose (182.00) from holding Ikena Oncology or give up 55.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. Nuvectis Pharma
Performance |
| Timeline |
| Ikena Oncology |
| Nuvectis Pharma |
Ikena Oncology and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Nuvectis Pharma
The main advantage of trading using opposite Ikena Oncology and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |